New medical discoveries show that stem cell treatment may help patients cope with both bone problems and brain diseases. Recent studies have also shown that stem cell therapy could reduce heart ...
Tirzepatide demonstrated superior cost-effectiveness compared to semaglutide for knee OA and obesity, with a $57,400 per QALY threshold. The Osteoarthritis Policy Model assessed cost-effectiveness, ...
Osteoarthritis is one of the most expensive and disabling conditions in modern medicine, driving joint replacements and ...
Stem cell therapy has come a long way since its early days. As an athlete who has undergone it twice, I know that the ...